3 most recent filings and news items mentioning MED. Updated every 60 seconds.
RestructuringJul 17, 2026Positive
Medifast announced the launch of the Trilivy system and new product formulations utilizing MetaVantage Technology. This strategic pivot to metabolic health addresses industry trends, potentially expanding the company's market relevance.
View filing at SEC.gov →
LeadershipJun 1, 2026Neutral
Jason Groves voluntarily resigned from Medifast effective May 29, 2026, receiving $35,648.42 in severance pay. The separation represents a routine executive departure with standard severance terms and benefits termination.
View filing at SEC.gov →
OtherMay 26, 2026Neutral
Medifast filed an amended and restated 2012 Share Incentive Plan designed to attract and retain executive talent through equity awards. The plan links compensation to company performance metrics and aligns employee interests with shareholder value creation.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.